1 drug(s) with this reaction
353 total reports
Weight Decreased has been reported as an adverse reaction across 1 drug(s) manufactured by Ipsen Biopharmaceuticals Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 353 adverse event reports mention weight decreased in connection with Ipsen Biopharmaceuticals Inc products.
This page provides a breakdown of which Ipsen Biopharmaceuticals Inc drugs are most commonly associated with weight decreased, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Ipsen Biopharmaceuticals Inc drugs have weight decreased listed in their FDA adverse event reports, sorted by report count:
In addition to weight decreased, the following adverse reactions have been reported across Ipsen Biopharmaceuticals Inc's drug portfolio:
1 drug(s) manufactured by Ipsen Biopharmaceuticals Inc have weight decreased listed in their FDA adverse event reports: LANREOTIDE ACETATE.
There are a combined 353 reports of weight decreased across 1 Ipsen Biopharmaceuticals Inc drug(s) in the FDA adverse event database.